FDA approves new pill to lower cholesterol

The Food and Drug Administration approved a new cholesterol pill from Merck that works in a different way from statins. The daily pill, called Lipfendra, is known as a PCSK9 inhibitor — a class of powerful cholesterol-lowering medication that had previously only been available as injections. NBC News medical contributor Natalie Azar has the details.

For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Subscribe to Here's the Scoop podcast: https://www.nbcnews.com/heres-the-scoop-daily-podcast » NBC News App: https://apps.nbcnews.com/mobile » Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621 » Visit NBCNews.Com: http://nbcnews.to/ReadNBC » Find NBC News on Facebook: http://nbcnews.to/LikeNBC » Follow NBC News on Twitter: http://nbcnews.to/FollowNBC » Follow NBC News on Instagram: http://nbcnews.to/InstaNBC

#news #fda #medicine